Clear Creek Financial Management LLC Grows Stock Position in The Procter & Gamble Company (NYSE:PG)

Clear Creek Financial Management LLC raised its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 17.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 5,294 shares of the company’s stock after buying an additional 778 shares during the period. Clear Creek Financial Management LLC’s holdings in Procter & Gamble were worth $917,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of PG. Acorn Creek Capital LLC boosted its position in Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after purchasing an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. boosted its position in Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after buying an additional 59 shares during the last quarter. Alera Investment Advisors LLC boosted its position in Procter & Gamble by 1.2% in the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after buying an additional 60 shares during the last quarter. Hudson Value Partners LLC boosted its position in Procter & Gamble by 4.1% in the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after buying an additional 60 shares during the last quarter. Finally, Traveka Wealth LLC boosted its position in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after buying an additional 60 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Analysts Set New Price Targets

PG has been the subject of a number of analyst reports. Jefferies Financial Group cut shares of Procter & Gamble from a “buy” rating to a “hold” rating and decreased their price objective for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. Citigroup increased their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. JPMorgan Chase & Co. boosted their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. DA Davidson boosted their price objective on Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a report on Monday, October 21st. Finally, Morgan Stanley lifted their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Nine analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $177.00.

Read Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Stock Down 0.0 %

Shares of Procter & Gamble stock opened at $165.10 on Monday. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The company has a market capitalization of $388.82 billion, a P/E ratio of 28.47, a PEG ratio of 3.57 and a beta of 0.42. The business’s fifty day moving average price is $171.62 and its two-hundred day moving average price is $168.07. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the prior year, the firm posted $1.83 EPS. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. As a group, research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.44%. Procter & Gamble’s payout ratio is 69.48%.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Jon R. Moeller sold 72,174 shares of the business’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $171.01, for a total value of $12,342,475.74. Following the sale, the chief executive officer now owns 263,158 shares of the company’s stock, valued at approximately $45,002,649.58. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Jon R. Moeller sold 72,174 shares of Procter & Gamble stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the transaction, the chief executive officer now owns 263,158 shares of the company’s stock, valued at $45,002,649.58. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 385,771 shares of company stock valued at $65,610,975. 0.18% of the stock is owned by corporate insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.